Teresa Esposito
Overview
Explore the profile of Teresa Esposito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Konig E, Nicoletti A, Pattaro C, Annesi G, Melotti R, Gialluisi A, et al.
Sci Rep
. 2021 Oct;
11(1):19582.
PMID: 34599261
Levodopa is the standard long-term dopamine replacement therapy to treat Parkinson's disease (PD) symptoms. With time, levodopa may induce debilitating dyskinesias (LID), the treatment of which represents a large clinically...
12.
Cammarota G, Esposito T, Azzolina D, Cosentini R, Menzella F, Aliberti S, et al.
Crit Care
. 2021 Jul;
25(1):268.
PMID: 34330320
Background: Noninvasive respiratory support (NIRS) has been diffusely employed outside the intensive care unit (ICU) to face the high request of ventilatory support due to the massive influx of patients...
13.
Gialluisi A, Reccia M, Modugno N, Nutile T, Lombardi A, Di Giovannantonio L, et al.
Mol Neurodegener
. 2021 Jun;
16(1):35.
PMID: 34148545
Background: Parkinson's disease (PD) is a neurodegenerative movement disorder affecting 1-5% of the general population for which neither effective cure nor early diagnostic tools are available that could tackle the...
14.
Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson's Disease
Tirozzi A, Modugno N, Palomba N, Ferese R, Lombardi A, Olivola E, et al.
Front Pharmacol
. 2021 May;
12:640603.
PMID: 33995045
Levodopa (L-Dopa), representing the therapeutic gold standard for the treatment of Parkinson disease (PD), is associated with side effects like L-Dopa induced dyskinesia (LID). Although several non-genetic and genetic factors...
15.
Napolitano F, Bruno G, Terracciano C, Franzese G, Palomba N, Scotto di Carlo F, et al.
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33807278
Pompe disease is an autosomal recessive disorder caused by a deficiency in the enzyme acid alpha-glucosidase. The late-onset form of Pompe disease (LOPD) is characterized by a slowly progressing proximal...
16.
Napolitano F, Terracciano C, Bruno G, De Blasiis P, Lombardi L, Gialluisi A, et al.
Neuropathol Appl Neurobiol
. 2021 Jan;
47(5):664-678.
PMID: 33393119
Background: Autophagic vacuolar myopathies (AVMs) are an emerging group of heterogeneous myopathies sharing histopathological features on muscle pathology, in which autophagic vacuoles are the pathognomonic morphologic hallmarks. Glycogen storage disease...
17.
Scimone C, Donato L, Alibrandi S, Esposito T, Alafaci C, DAngelo R, et al.
Biochim Biophys Acta Mol Basis Dis
. 2020 Sep;
1866(12):165956.
PMID: 32877751
Cerebral cavernous malformations (CCM) are lesions affecting brain capillaries that appear with a mulberry-like morphology. This shape results from the enlarged and tangled microvessels having defective endothelial cell junctions, few...
18.
Scotto di Carlo F, Pazzaglia L, Mumm S, Benassi M, De Chiara A, Franchi A, et al.
J Bone Miner Res
. 2020 Feb;
35(10):1974-1980.
PMID: 32106343
Neoplastic transformation is a rare but serious complication of Paget's disease of bone (PDB), occurring in fewer than 1% of individuals with polyostotic disease. Their prognosis is poor, with less...
19.
Gialluisi A, Reccia M, Tirozzi A, Nutile T, Lombardi A, De Sanctis C, et al.
Front Neurol
. 2020 Jan;
10:1362.
PMID: 31998221
Parkinson Disease (PD) is a complex neurodegenerative disorder characterized by large genetic heterogeneity and missing heritability. Since the genetic background of PD can partly vary among ethnicities and neurological scales...
20.
Scotto di Carlo F, Pazzaglia L, Esposito T, Gianfrancesco F
J Bone Miner Res
. 2020 Jan;
35(8):1387-1398.
PMID: 31991009
Paget's disease of bone (PDB) is a late-onset disorder frequently caused by mutations in the SQSTM1 gene, leading to hyperactive osteoclasts and resulting in bone pain, deformities, and fractures. However,...